BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Ralinepag readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Ralinepag\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT03683186-524@assetmemo.bio
DTSTAMP:20261121T005637Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Ralinepag: Phase 3 readout est. (NCT03683186)
DESCRIPTION:Ralinepag\, phase 3\, Pulmonary Arterial Hypertension.\nStudy: 
 A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subje
 cts With PAH Via an Open-Label Extension\nEstimated primary completion: De
 cember 2026. This is a ClinicalTrials.gov estimate\, not a confirmed reado
 ut date\, and it can move.\nDrug page: https://assetmemo.bio/drug/ralinepa
 g#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT03
 683186
URL:https://assetmemo.bio/drug/ralinepag#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
